Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.


  • Watching eyes prevent littering

  • 45 percent increase in mortality from law enforcement from 1999 to 2013, report shows

  • Magnesium ions show promise in slowing progression of Alzheimer's disease in mice

  • why and when straight women form close friendships with gay men

  • First language wires brain for later language-learning

  • Unfriending on Facebook more likely from politically active users

  • Decline in cognitive ability leads to fear of upfront costs

  • Early progress reported in designing drugs that target 'disordered' proteins

  • Christmas period may reduce quality of life for many Europeans

  • Study 'opens gate' to understanding depression